Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Meihua International Medical Technologies Co Equity-to-Asset?
Meihua International Medical Technologies CoMHUAF 59 Equity-to-Asset is 0.91 as of Dec. 2025, which is 8% above its 10-year median of 0.84. GuruFocus rates MHUAF with a GF Score™ of 59/100 and a GF Value™ of $25.90 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Meihua International Medical Technologies Co ranks better than 94.36% on this metric.
MHUAF's Equity-to-Asset is ranked better than 94.36% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs MHUAF: 0.91
Meihua International Medical Technologies Co (OTCPK:MHUAF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Meihua International Medical Technologies Co Equity-to-Asset Related Terms
Meihua International Medical Technologies Co Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co Equity-to-Asset Chart
Meihua International Medical Technologies Co Annual Data
MHUAF vs UEEC, CUPR, LUCY: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Meihua International Medical Technologies Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Meihua International Medical Technologies Co Equity-to-Asset vs Medical Devices & Instruments Industry
Meihua International Medical Technologies Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Meihua International Medical Technologies Co (MHUAF) has a Equity-to-Asset of 0.91 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Meihua International Medical Technologies Co and its competitors. This is near median its historical median of 0.84. Over the past decade, Meihua International Medical Technologies Co's Equity-to-Asset has ranged from 0.79 to 0.91. According to the industry distribution chart, Meihua International Medical Technologies Co ranks #48 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 5.6%.
Is Meihua International Medical Technologies Co's Equity-to-Asset too high?
Meihua International Medical Technologies Co's current Equity-to-Asset of 0.91 is near median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 0.91. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Meihua International Medical Technologies Co's value of 0.91 is 42.2% above this industry median. Based on the distribution chart, Meihua International Medical Technologies Co ranks #48 out of 851 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Meihua International Medical Technologies Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meihua International Medical Technologies Co's Equity-to-Asset compare to UEEC and CUPR?
According to the Medical Devices & Instruments industry distribution chart, Meihua International Medical Technologies Co ranks #48 out of 851 companies for Equity-to-Asset. This places Meihua International Medical Technologies Co in the top 6% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.64. Meihua International Medical Technologies Co's value of 0.91 is 42.2% above this benchmark. Historically, Meihua International Medical Technologies Co's own Equity-to-Asset has ranged from 0.79 to 0.91 over the past decade. While the company's 10-year median is 0.84 vs. the industry median of 0.64, Meihua International Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Meihua International Medical Technologies Co's current Equity-to-Asset of 0.91 is 42.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Meihua International Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Meihua International Medical Technologies Co's current Equity-to-Asset is 0.91, which is near median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meihua International Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co (MHUAF) is currently considered Possible Value Trap. The stock's GF Value™ is $25.90, compared to a current price of $7.00 — trading 73% below its estimated fair value. The current Equity-to-Asset is 0.91, which is near median its 10-year median of 0.84 and 42.2% above the Medical Devices & Instruments industry median of 0.64. Meihua International Medical Technologies Co's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Meihua International Medical Technologies Co (MHUAF), the current Equity-to-Asset is 0.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Meihua International Medical Technologies Co (MHUAF) Overvalued in 2026?
Based on GuruFocus' analysis, Meihua International Medical Technologies Co stock appears to be undervalued.
The current stock price of $7.00 is trading 73% below its estimated GF Value™ of $25.90.
GuruFocus considers Meihua International Medical Technologies Co to be Possible Value Trap.
Key valuation signals for MHUAF:
Equity-to-Asset: 0.91 (near median its 10-year median of 0.84)
GF Value™: $25.90 vs. price of $7.00 (73% below fair value)
Industry Position: 42.2% above the Medical Devices & Instruments median (#48 of 851)
No single metric tells the full story. See the MHUAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
59GF Score
Get the complete analysis for MHUAF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MHUAF has been successfully added to your 
